MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517048731 A) filed by Peptomyc, S. L.; Fundacio Privada Institut D'Investigacio Oncologica De Vall Hebron; and Institucio Catalana De Recerca I Estudis Avancats, Barcelona, Spain, on May 20, for 'combination therapy for the treatment of cancer.'
Inventor(s) include Soucek, Laura; Giuntini, Fabio; and Masso-Valles, Daniel.
The application for the patent was published on June 6, under issue no. 23/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to a combination of a PARP inhibitor with Omomyc, a functionally equivalent variant thereof, a conjugate comprising Omomyc or said functionally equivalent v...